AKT1 and diabetic cardiomyopathy: Suppressing IGFBP3 expression in mice with diabetic cardiomyopathy can alleviate cardiac fibrosis and enhance cell proliferation while inducing AKT and ERK phosphorylation [41]; this potentially plausible signaling pathway needs to be explored further.